Patient information leaflet for the IPerGlio public dashboard

The ERA PerMed Project „Improving personalized glioblastoma care by intertwined immunomics and artificial intelligence approaches“ (IPerGlio) seeks to identify prognostic markers that will enhance the quality of care for glioblastoma patients. A key goal of the project is to contribute to the dissemination of knowledge about glioblastoma by making research results publicly available on a dashboard designed to be as accessible as possible for lay users. The patient information brochure was co-developed with stakeholders to provide prospective and current patients and their caregivers with clear and accessible information about the goals of the project and the journey of their data. It is available in English, Italian, Norwegian, German, Spanish, and French. IPerGlio is funded by the European Research Area Network for Personalized Medicine (ERA PerMed), a European research consortium cofounded by the European Commission.